Saving an estimated 50,000 lives and $12 billion in health care costs is something to celebrate.  Congratulations to the 3,700 acute-care hospitals that have participated in one of the Hospital Engagement Networks (HENs) that are part of the Centers for Medicare & Medicaid Services’ Partnership for Patients. You are a big reason that, between 2010 and 2013, hospital-acquired conditions fell by an impressive 17%, according to a report (http://www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/pfp/hacrate2013.pdf) from the Agency for Healthcare Research and Quality on the national HAC rate for Partnership for Patients measures. Adverse drug events (down 44%), pressure ulcers (down 21%) and catheter-associated urinary tract infections (down 14%) are just some of the areas of improvement. Congratulations, too, to AHA’s Health Research & Educational Trust, one of 17 organizations recently selected (http://news.aha.org/article/150925-ahahret-selected-to-continue-hospital-engagement-network) to continue its HEN for another year.

Headline
The Federal Office of Rural Health Policy’s Rural Health Redesign Center will host a webinar on Sept. 24 at 2 p.m. ET, where hospital CEOs will discuss the…
Headline
The Food and Drug Administration has issued an early alert for all automated Impella controllers by Abiomed following an issue that has caused three deaths and…
Headline
Boston Scientific, a large supplier of medical devices, said in an Aug. 26 statement posted on its website that on Aug. 25 it “identified a cybersecurity…
Headline
Two individuals in Pennsylvania have died from measles, the Pennsylvania Department of Health announced Aug. 25. They are the first deaths from the disease in…
Headline
President Trump signed an executive order Aug. 10 revamping the federal government’s recommended childhood vaccine schedule. The order divides immunizations…
Headline
The Food and Drug Administration Aug. 5 approved the first mRNA-based flu vaccine, called mFlusiva. The vaccine is manufactured by Moderna and was approved for…